摘要
靶向治疗,基于根本的基因改变的癌症治疗,作为一种首选治疗方法迅速获得青睐。迄今为止,虽然天然产物是一种生物多样性非常丰富的候选药物的来源,但是只有少数的天然产物已经被证实为有效的癌症靶向治疗药物,这很大程度上是由于目前高通量筛选方法的不兼容性。在这篇文章中,我们对用于天然产物化合物活性筛选的斑马鱼发育筛选进行了综述,并与大家分享目标信号通路的相关信息。任何从表型发育缺陷的斑马鱼胚胎中鉴定出来的能扰乱信号通路的活性化合物都为人类癌症的靶向治疗提供了一个机会。这个模型提供了一个从天然产物中寻找癌症靶向治疗药物的有前途的工具。
关键词: 天然产物,新颖的药物靶点,信号通路,癌症靶向治疗,目标识别,斑马鱼表型分析
图形摘要
Current Cancer Drug Targets
Title:Zebrafish: Predictive Model for Targeted Cancer Therapeutics from Nature
Volume: 14 Issue: 8
Author(s): Nursafwana Syazwani Zulkhernain, Soo Hwang Teo, Vyomesh Patel and Pei Jean Tan
Affiliation:
关键词: 天然产物,新颖的药物靶点,信号通路,癌症靶向治疗,目标识别,斑马鱼表型分析
摘要: Targeted therapy, the treatment of cancer based on an underlying genetic alteration, is rapidly gaining favor as the preferred therapeutic approach. To date, although natural products represent a rich resource of bio-diverse drug candidates, only a few have been identified to be effective as targeted cancer therapies largely due to the incompatibilities to current high-throughput screening methods. In this article, we review the utility of a zebrafish developmental screen for bioactive natural product-based compounds that target signaling pathways that are intimately shared with those in humans. Any bioactive compound perturbing signaling pathways identified from phenotypic developmental defects in zebrafish embryos provide an opportunity for developing targeted therapies for human cancers. This model provides a promising tool in the search for targeted cancer therapeutics from natural products.
Export Options
About this article
Cite this article as:
Nursafwana Syazwani Zulkhernain, Soo Hwang Teo, Vyomesh Patel and Tan Jean Pei, Zebrafish: Predictive Model for Targeted Cancer Therapeutics from Nature, Current Cancer Drug Targets 2014; 14 (8) . https://dx.doi.org/10.2174/1568009614666141028121347
DOI https://dx.doi.org/10.2174/1568009614666141028121347 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vascular Biomarkers in Asthma and COPD
Current Topics in Medicinal Chemistry Melanocortins As Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives
Current Medicinal Chemistry Overview of the Structure and Function of Protein Kinases
Current Enzyme Inhibition Transmembrane Protein 166 and its Significance
Protein & Peptide Letters Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia via mir-491
Anti-Cancer Agents in Medicinal Chemistry A Fluorescent Alkyllysophospholipid Analog Exhibits Selective Cytotoxicity Against the Hormone-Insensitive Prostate Cancer Cell Line PC3
Anti-Cancer Agents in Medicinal Chemistry Biosynthetic Pathways to Glycosidase Inhibitors
Current Chemical Biology Bioactives in Disease Prevention and Health Promotion: Exploiting Combinatorial Effects
Current Bioactive Compounds Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Current Pharmaceutical Design Suramin: Clinical Uses and Structure-Activity Relationships
Mini-Reviews in Medicinal Chemistry In Silico Prediction Models for Blood-Brain Barrier Permeation
Current Medicinal Chemistry Vascularization of Biomaterials for Bone Tissue Engineering: Current Approaches and Major Challenges
Current Angiogenesis (Discontinued) Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
Anti-Cancer Agents in Medicinal Chemistry Kinase Inhibitors with Redox and Anti-inflammatory Activities
Current Topics in Medicinal Chemistry Purinergic Receptors and Pain
Current Pharmaceutical Design The Potential for Genetically Altered Microglia to Influence Glioma Treatment
CNS & Neurological Disorders - Drug Targets Resveratrol and Analogues: A Review of Antioxidant Activity and Applications to Human Health
Recent Patents on Food, Nutrition & Agriculture Nanoparticle Based Delivery of Protease Inhibitors to Cancer Cells
Current Medicinal Chemistry MicroRNA in the Pathogenesis and Prognosis of Esophageal Cancer
Current Pharmaceutical Design